RAPGEF2 and schizophrenia: Conditional knockout of either RAPGEF2 or RAPGEF6 in mice caused hyperlocomotion and deficits in learning and memory, which have been likened to symptoms observed in schizophrenia patients (Maeta et al., 2018).